a month ago
IONS
AnalystsJoon LeeJoon Lee's Stock Forecasts
AnalystsJoon Lee
Sectors:
Analyst Ranking
Top 2%
#86 out of 5557 analysts
Average Return
+40.11%
Win Rate
60%89 out of 148
Risk vs Reward
Poor
Good
Joon Lee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +885.37% | $33.55 | $330.59 | 2025-03-03 - 2026-03-02 | Strong Buy |
Verona Pharma PLCVRNA | +548.82% | $14.46 | $93.82 | 2024-06-28 - 2025-06-27 | Strong Buy |
Viking Therapeutics IncVKTX | +470.38% | $10.87 | $62.00 | 2023-10-02 - 2024-10-01 | Strong Buy |
Intellia Therapeutics IncNTLA | +418.87% | $25.44 | $132.00 | 2020-10-27 - 2021-10-26 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-29 - 2024-03-28 | Strong Buy |
Joon Lee Analyst Color
Get additional color on Joon Lee's coverage of popular stocks
a month ago
BBIO
2 months ago
VKTX
8 months ago
VRTX
9 months ago
PRAX
10 months ago
JAZZ
a year ago
BMRN
a year ago
WVE
a year ago
PRAX
a year ago
ALKS
a year ago
BMRN
a year ago
PRAX
a year ago
ARGX
a year ago
JAZZ
a year ago
PTCT
2 years ago
CORT
2 years ago
AXSM
2 years ago
CRSP
2 years ago
AXSM
2 years ago
ARGX
2 years ago
AXSM
2 years ago
VRNA
2 years ago
WVE
2 years ago
CPRX
2 years ago
ARGX
Joon Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rapport Therapeutics IncRAPP | 3 | Strong Buy | $64.00 | +147.58% | Maintains | 8 days ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $329.00 | +110.02% | Maintains | 13 days ago |
Wave Life Sciences IncWVE | 5 | Strong Buy | $11.00 | +248.65% | Initiates Coverage On | a month ago |
Biomarin Pharmaceutical IncBMRN | 5 | Strong Buy | $88.00 | +55.20% | Assumes | a month ago |
Ionis Pharmaceuticals IncIONS | 1 | Strong Buy | $88.00 | +222.23% | Upgrades | a month ago |
Crispr Therapeutics AgCRSP | 6 | Hold | $52.00 | +22.01% | Initiates Coverage On | a month ago |
Uniqure NvQURE | 1 | Strong Buy | $48.00 | +94.88% | Assumes | a month ago |
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $92.00 | +17.69% | Assumes | a month ago |
Ascendis Pharma AASND | 1 | Strong Buy | $269.00 | +0.72% | Assumes | a month ago |
Solid Biosciences IncSLDB | 2 | Strong Buy | $20.00 | +185.71% | Initiates Coverage On | a month ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Hold | $16.00 | -1.66% | Initiates Coverage On | a month ago |
Viking Therapeutics IncVKTX | 11 | Strong Buy | $94.00 | +240.83% | Initiates Coverage On | a month ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $525.00 | -3.25% | Maintains | 8 months ago |
Praxis Precision Medicines IncPRAX | 8 | Strong Buy | $700.00 | +115.54% | Maintains | 9 months ago |
Jazz Pharmaceuticals PLCJAZZ | 4 | Strong Buy | $230.00 | -4.31% | Maintains | 10 months ago |
Alkermes PLCALKS | 3 | Strong Buy | $55.00 | +17.07% | Maintains | a year ago |
Intellia Therapeutics IncNTLA | 5 | Strong Buy | $14.00 | N/A | Reiterates | a year ago |
Argenx SeARGX | 13 | Strong Buy | $918.00 | N/A | Maintains | a year ago |
Ptc Therapeutics IncPTCT | 2 | Strong Buy | $86.00 | N/A | Maintains | a year ago |
Sage Therapeutics IncSAGE | 8 | Hold | $9.00 | N/A | Maintains | a year ago |
Arvinas IncARVN | 6 | Strong Buy | $21.00 | N/A | Maintains | 2 years ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $200.00 | N/A | Maintains | 2 years ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Verona Pharma PLCVRNA | 6 | Strong Buy | $57.00 | N/A | Reiterates | 2 years ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $36.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 7 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Cormedix IncCRMD | 6 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 2 | Hold | $60.00 | N/A | Downgrades | 2 years ago |
Adverum Biotechnologies IncADVM | 6 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 7 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Taysha Gene Therapies IncTSHA | 7 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Concert Pharmaceuticals IncCNCE | 2 | Strong Buy | $25.00 | N/A | Maintains | 4 years ago |
Aptinyx IncAPTX | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Korsana Biosciences IncKRSA | 1 | Strong Buy | $1,960.00 | N/A | Initiates Coverage On | 5 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $50.00 | N/A | Upgrades | 5 years ago |
Translate Bio IncTBIO1 | 2 | Hold | $360.00 | N/A | Downgrades | 6 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $34.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.